GlassScriptPhysician profile
Steven Wheeler
NPI 1164015624
$1,494.96
in general payments reported to CMS, 2019-2025
11 companies · $519 in 2025
The $519 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $156 · 2023: $358 · 2024: $462 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.98 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $609.11 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $261.67 | 2022-2025 | |
| Harmony Biosciences LLC | $244.37 | 2022-2025 | Wakix |
| Astrazeneca Pharmaceuticals LP | $113.38 | 2022-2025 | Tezspire |
| Lilly USA, LLC | $72.97 | 2025 | Zepbound |
| Mallinckrodt Hospital Products INC. | $58.18 | 2024-2025 | Acthar |
| Merck Sharp & Dohme LLC | $44.97 | 2024-2025 | Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.69 | 2022-2024 | Ofev |
| Regeneron Healthcare Solutions, INC. | $26.68 | 2025 | Dupixent |
| Liquidia Technologies, INC. | $20.88 | 2025 | Yutrepia |
| Avadel Cns Pharmaceuticals, LLC | $15.06 | 2024 | Lumryz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.